These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16730315)

  • 1. Metastatic tumors in bone marrow: histopathology and advances in the biology of the tumor cells and bone marrow environment.
    Cotta CV; Konoplev S; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2006 Jun; 10(3):169-92. PubMed ID: 16730315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Micrometastases in pediatric oncology].
    Bernard F; Aerts I; Margueritte G; Astruc J
    Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can detection of cancer cells in bone marrow and peripheral blood be used in diagnosis and patient monitoring?].
    Werther K; Brünner NA; Nielsen HJ
    Ugeskr Laeger; 1998 Oct; 160(41):5923-6. PubMed ID: 9786030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the pathologic diagnosis and biology of acute myeloid leukemia.
    Konoplev S; Bueso-Ramos CE
    Ann Diagn Pathol; 2006 Feb; 10(1):39-65. PubMed ID: 16414545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ancillary studies in the detection of residual disease in plasma cell myeloma in bone marrow.
    Zhao X; Huang Q; Slovak M; Weiss L
    Am J Clin Pathol; 2006 Jun; 125(6):895-904. PubMed ID: 16690489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Micrometastases in patients with colorectal cancer: markers for metastatic potential or proofs for residual disease].
    Iovchev I; Trifonov D; Popkharitov A; Khadzhipetkov F; Nikolov S
    Khirurgiia (Sofiia); 2004; 60(4-5):18-21. PubMed ID: 16042058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow metastasis in solid tumors.
    Mohanty SK; Dash S
    Indian J Pathol Microbiol; 2003 Oct; 46(4):613-6. PubMed ID: 15025356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow involvement by metastatic solid tumors.
    Sharma S; Murari M
    Indian J Pathol Microbiol; 2003 Jul; 46(3):382-4. PubMed ID: 15025279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
    Gretschel S; Astrosini Ch; Vieth M; Jöns T; Tomov T; Höcker M; Schlag PM; Kemmner W
    Eur J Surg Oncol; 2008 Jun; 34(6):642-7. PubMed ID: 18023552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
    Cao D; Humphrey PA; Allan RW
    Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease.
    Wetterwald A; van der Pluijm G; Que I; Sijmons B; Buijs J; Karperien M; Löwik CW; Gautschi E; Thalmann GN; Cecchini MG
    Am J Pathol; 2002 Mar; 160(3):1143-53. PubMed ID: 11891210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow.
    Bomken SN; Redfern K; Wood KM; Reid MM; Tweddle DA
    J Clin Pathol; 2006 Sep; 59(9):927-9. PubMed ID: 16565222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
    Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
    Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the detection of bone marrow micrometastases: A promising area for research or just another false hope? A review of the literature.
    Athanassiadou P; Grapsa D
    Cancer Metastasis Rev; 2006 Dec; 25(4):507-19. PubMed ID: 17160555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric detection of small cell lung cancer cells with aberrant CD45 expression in micrometastatic bone marrow.
    Danbara M; Yoshida M; Kanoh Y; Jiang SX; Masuda N; Akahoshi T; Higashihara M
    Jpn J Clin Oncol; 2009 Nov; 39(11):771-5. PubMed ID: 19674995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical significance of detecting small numbers of carcinoma].
    Mimori K; Masuda T; Kataoka A; Mori M
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):756-61. PubMed ID: 11432341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
    Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
    Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells and bone marrow micrometastasis.
    Alix-Panabières C; Riethdorf S; Pantel K
    Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of disseminated tumor cells in breast cancer.
    Slade MJ; Coombes RC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.